Text
Computer-aided drug design : QSAR, molecular docking, virtual screening, homology and pharmacophore modeling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783111434742
3111434745
- Maße
-
24 cm, 606 g
- Umfang
-
XII, 339 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
- Reihe
-
De Gruyter graduate
- Schlagwort
-
Arzneimitteldesign
Computerunterstütztes Verfahren
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
De Gruyter
- (wann)
-
[2024]
- Urheber
-
Thakur, Aman (Verfasser)
Mehta, Vineet (Verfasser)
Nagu, Priyanka (Verfasser)
Goutam, Kiran (Verfasser)
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
- 17.02.2026, 13:03 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Text
Beteiligte
- Thakur, Aman (Verfasser)
- Mehta, Vineet (Verfasser)
- Nagu, Priyanka (Verfasser)
- Goutam, Kiran (Verfasser)
- Walter de Gruyter GmbH & Co. KG (Verlag)
- De Gruyter
Entstanden
- [2024]
Ähnliche Objekte (12)
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
Semiempirical MO-methods for QSAR and docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Regioselectivity of CYP2B6 : homology modelling, molecular dynamics simulation, docking
QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
Semiempirical MO-methods for QSAR and docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Regioselectivity of CYP2B6 : homology modelling, molecular dynamics simulation, docking
QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
Semiempirical MO-methods for QSAR and docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Regioselectivity of CYP2B6 : homology modelling, molecular dynamics simulation, docking
QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA